---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000867"
form_type: "8-K"
ticker: "NUS"
cik: "0001021561"
company_name: "NU SKIN ENTERPRISES, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T02:37:18.380384+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Nu Skin Q4 prelim revenue at high end of guidance; closed Mavely deal for $250M

## Summary
- Q4 2024 preliminary revenue at high end of company's guidance range.
- Recently closed strategic transaction of Mavely for $250 million.
- Full Q4 and FY2024 results to be announced on Feb. 13, 2025.
- CEO Ryan Napierski and CFO James Thomas to present at ICR Conference on Jan. 14.

## SEC filing metadata
- accession: 0001140361-25-000867
- form_type: 8-K
- ticker: NUS
- cik: 0001021561
- company_name: NU SKIN ENTERPRISES, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1021561/000114036125000867/0001140361-25-000867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1021561/000114036125000867/ef20041411_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000867
- JSON: https://secwatch.observer/filing/0001140361-25-000867.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.